Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder

NCT00120250 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00120250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00120250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
June 30, 2008
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorders